In the dynamic world of peptide supply, particularly in Indonesia, the quality and reliability of suppliers are paramount.
Mindtek, established by a healthcare expert with a notable background in both Indonesia and the USA, has set high standards in the field. The founder’s achievements include introducing MCT oil to Indonesia in 2015, peptides in 2017, NAD+ in 2018, and exosomes in 2023, along with launching one of the USA’s first direct-to-consumer blood testing companies.
Mindtek has watched this market go from crickets to millions over the course of the last 6 years.